Nebu-Flow, a Glasgow, Scotland, UK-based provider of a nebulizer platform, recently announced that they have raised an additional $5.9M in funding. This funding round was led by SCVC and was also supported by Scottish Enterprise, Foresight WAE Technology, SIS Ventures, Ascension, and Conduit EIS Impact Fund. The company plans to use these funds to accelerate the development of inhaled drugs for patients who suffer from respiratory disorders.
Founded by Dr Elijah Nazarzadeh (CEO) and Dr John Pritchard (Chair), Nebu-Flow is at the forefront of developing a new generation of nebulizers that will enable the inhalation delivery of life-changing treatments.
Dr. Nazarzadeh expressed his excitement about the news, stating that their mission is to revolutionize respiratory drug delivery. With this new investment, Nebu-Flow is now able to speed up their development activities and get closer to making inhalation delivery of RNA-based formulations a reality.
The company is now focused on moving forward with the final product development and commercialization stages, with the strong support of SCVC and their other investors. As they continue to make strides in the field of respiratory drug delivery, Nebu-Flow is poised to make a significant impact on the lives of patients with respiratory disorders. With the leadership of Dr. Nazarzadeh and Dr. Pritchard, the company is well-positioned to bring about positive change in the healthcare industry.
# | Investor | Sector | Stage | Activity | Team | Connect |
---|---|---|---|---|---|---|
1 | SCVC | 1 investment(s) investment(s) | more info | |||
2 | Scottish Enterprise | 14 investment(s) investment(s) | 7 contacts contacts | |||
3 | Foresight WAE Technology | 1 investment(s) investment(s) | more info | |||
4 | SIS Ventures | 3 investment(s) investment(s) | 5 contacts contacts | |||
5 | Ascension | 5 investment(s) investment(s) | 11 contacts contacts |
Click here for a full list of 6,481+ startup investors in the UK